DGAP-News: RHÖN-KLINIKUM AG (english)
RHÖN-KLINIKUM AG: Results Press Conference in Frankfurt/MainRHÖN-KLINIKUM AG / Final Results/Quarter Results
23.04.2009
Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this
announcement.
---------------------------------------------------------------------------
Results for financial year 2008:
* Also in the 20th year of its stock market listing, the Company has
comfortably met its forecasts and demonstrated its operating performance
* 1.6 million patients treated (+ 6.7%)
* Revenues: EUR 2.1 billion (+ 5.2%)
* Once again a disproportionate rise in net consolidated profit to EUR
122.6 million (+ 10.3%)
* EBITDA climbs to EUR 262.8 million (+ 5.4%)
* EBIT increased to EUR 172.1 million (+ 9.3%)
* Dividend proposal: EUR 0.35 per ordinary share
Q1 2009 results:
* Good start into new financial year
* Over 450,000 patients treated already in the first quarter (+ 10.3%)
* Revenues rise to EUR 559.1 million (+ 7.4%)
* Net consolidated profit increased to EUR 30.7 million (+ 3.7%)
* EBITDA climbs to EUR 67 million (+ 4.4%)
* EBIT of EUR 42.8 million (- 2.1%) slightly below previous year's level
due to negative one-off effects
Forecast for the further course of 2009:
* Environment for the hospital market still challenging
* Forecast for 2009 reaffirmed: revenues of EUR 2.3 billion, profit of EUR
130 million within a fluctuation range of plus or minus EUR 5 million based
on risks and opportunities
Bad Neustadt a. d. Saale/Frankfurt am Main, 23 April 2009 ----- At its
annual Results Press Conference held today in Frankfurt am Main, the Board
of Management of RHÖN-KLINIKUM AG confirmed the trend figures already
published in February. 'We have met our forecast for 2008, expanded our
medical offering and comfortably maintained our growth course', said
Wolfgang Pföhler, chairman of the Board of Management of the hospital
group.
Results for financial year 2008
In financial year 2008, a total of 1,647,972 (+ 6.7%) patients were treated
at the Group's 48 hospitals and 20 medical care centres (MVZs). Revenues
rose to EUR 2.13 billion (+ 5.2%). With the net consolidated profit of EUR
122.6 million (+10.3%), the Group has once again clearly demonstrated its
restructuring expertise.
EBITDA (earnings before interest, depreciation/amortisation and tax) rose
to EUR 262.8 million (+ 5.4%). EBIT (operating result) climbed to EUR 172.1
million (+ 9.3%). Operating cash flow rose to EUR 213.8 million (+ 11.9%).
As at 31 December 2008, the number of employees at the Group (by headcount)
was 33,679 (+ 4.5%). Earnings per ordinary share stood at EUR 1.13
(previous year: EUR 1.03).
As the Group's biggest subsidiary, Universitätsklinikum Gießen und Marburg
GmbH raised its earnings as planned to EUR 2.2 million. 'At both sites we
have made extensive investments in good medical care. Because of the high
patient demand for our services, we have also increased our staffing of
doctors and nurses here', explained Gerald Meder, deputy chairman of the
Board of Management.
On 10 June 2009, the Board of Management and the Supervisory Board will
propose a dividend of EUR 0.35 (previous year: EUR 0.28) per ordinary
non-par share with dividend entitlement (DE 0007042301; 103,680,000 non-par
shares).
Q1 2009 results
The Management is pleased with the start the Company has made into
financial year 2009. 'We have got off to a good start into the new year',
emphasised Wolfgang Pföhler.
Already in the first three months, the Group treated 452,319 patients (+
10.3%). Revenues rose to EUR 559.1 million (+ 7.4%). At EUR 30.7 million (+
3.7%), net consolidated profit for the first time exceeded EUR 30 million
after the first quarter.
EBITDA climbed to EUR 67.0 million (+ 4.4%) EBIT stood at EUR 42.8 million
(- 2.1%), which is slightly below the level of the previous year. This
stems among other things from the first-time consolidation of the hospitals
in Warburg and Nordenham. Operating cash flow is at EUR 57.6 million (+
10.8%). At the end of the first quarter, earnings per share stood at EUR
0.28 (+ 3.7%). As at 31 March 2009, the Group had 33,958 employees (+
5.1%).
'We achieved our targets for 2008 and have continued our growth in the
first quarter of 2009. Our financial structures are stable and oriented
long-term' explained Dr. Erik Hamann, the Company's CFO.
Forecast for the further course of 2009
'Faced with one of the most severe economic and financial crises in
decades, many industries are bracing themselves for a steep slump in
growth. The situation in the healthcare industry as a largely non-cyclical
sector has so far remained stable', Pföhler emphasised.
With the German Hospital Finance Reform Act having entered into force, the
regulatory framework for the hospital market has been largely mapped out
for the current year. The Hospital Finance Reform Act will essentially
result in the existing remuneration system for inpatient services being
preserved.
'We have some challenges to tackle', said Pföhler, 'and will cushion the
unexpected burdens from the prolonging of the convergence phase by taking
specific counter-measures. Over the past years we have proven that we know
how to cope with changes in the regulatory environment resulting from new
legislation. And that is what we plan to do in 2009 also.'
The Management confirms the forecast for 2009. The Group will achieve
revenues of EUR 2.3 billion and a net consolidated profit of EUR 130
million within a possible fluctuation range of plus or minus EUR 5 million.
'We are optimistic that we will achieve our growth targets and will
steadfastly continue our transformation from classic hospital operator to
integrated healthcare provider', stated Wolfgang Pföhler in
closing.
Dr. Irmgard Stippler
Board Member for Communication and IT
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Tel.: +49 (0)9771 65-1321
Fax: +49(0)9771 65-1306
E-Mail: kommunikation@rhoen-klinikum-ag.com
23.04.2009 Financial News transmitted by DGAP
---------------------------------------------------------------------------
Language: English
Issuer: RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Deutschland
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: fire.ir@rhoen-klinikum-ag.com
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: MDAX
Listed: Regulierter Markt in Frankfurt (Prime Standard), München;
Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------------
Weitere Informationen: www.dpa-AFX.de
